Search This Blog

Saturday, September 10, 2022

Novartis Cosentyx: symptom improvements in hidradenitis suppurativa in pivotal Phase III

https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/Novartis-Cosentyx-R-shows-clinically-meaningful-symptom-improvements-in-patients-with-hidradenitis-41737395/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)